Alere shareholders want change, and they want it now
This article was originally published in Clinica
Executive Summary
On the eve of Alere’s first-quarter results, a group of shareholders has proposed three candidates for the company’s board, bemoaning the firm’s profligate acquisition strategy and “the destruction of stockholder value”.